April 17, 2018

Trethera Corporation Developing TRE-515 to Treat Myelodyspastic Syndromes and Acute Myeloid Leukemia

TRE-515 Therapy Targets Multiple Pathways to Improve Treatment Efficacy Over Single-Agent Approaches Trethera Corporation, a Los Angeles-based clinical-stage biopharmaceutical company, is developing cancer treatments for orphan blood cancers with high unmet needs.  Trethera’s lead program combines TRE-515, a novel deoxycytidine kinase inhibitor, with de novo pathway inhibitors. TRE-515 has been […]
April 17, 2018

Geneius Developing Innovative T-Cell Therapy that Targets Viral and Neoantigens

Targeted DiversiTy™ Therapy Promotes Surveillance and Destruction of Cancer Cells By Re-Educating Patients’ Own T Cells Geneius is an immuno-oncology company based in Natick, MA, that is focused on T-cell immunotherapies for cancer and infections.  Geneius has developed an innovative autologous, adoptive T-cell therapy technology (Targeted DiversiTy™) that promotes surveillance […]
April 17, 2018

Vitanova Biomedical Utilizes Photodynamic Therapy to Kill Aggressive Cancer Cells

Light-Activated Intracellular Acidosis Therapy May Cause Cancer Cells to Undergo Rapid Apoptosis Vitanova Biomedical Inc., a San Antonio-based early-stage biotechnology company, is currently conducting pre-clinical trials on a proprietary Light-Activated Intracellular Acidosis therapy that potentially kills multiple types of aggressive cancer cells.  Vitanova Biomedical is working with clinical research organization […]
April 17, 2018

Immunicom Developing Subtractive Device-Based Cancer Treatment Platform

Blood-Filtering Device Treats Cancer By Removing Blocking Proteins Released By Cancer Cells Immunicom Inc., a San Diego-based immuno-oncology company, is developing a proprietary subtractive device-based technology platform as a novel approach to treating cancer.  Immunicom’s immunotherapy platform (Immunopheresis™) potentially treats all cancer types and other terminal diseases through a blood-filtering […]
December 2, 2017

BioFuse’s Technology to “Fuse” Torn or Surgically Divided Tissues

BioFuse Medical Technologies Inc. is a privately-held medical technology and surgical device company that has developed a unique radiofrequency (RF) vessel-sealing platform technology. BioFusion™, the core technology developed by BioFuse Medical Technologies Inc., is an advanced high frequency electrosurgical system which incorporates a unique and proprietary method of controlling and […]
December 2, 2017

NovoCure’s Non-Invasive Cancer Treatment to Target Solid Tumors

Novocure is an oncology company working to develop a novel cancer treatment utilizing a proprietary therapy called Tumor Treating Fields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product is approved for the treatment of adult patients with glioblastoma. The […]
November 22, 2017

UroGen Pharma’s Immunotherapy Product to Treat High-Grade Non-Muscle Invasive Bladder Cancer

UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology. They currently have an innovative and broad pipeline of product candidates that they believe can overcome the deficiencies of current treatment options for a […]
November 22, 2017

Altor Bioscience’s Cytokine Technology Platforms to Combat Cancers and Infectious Diseases

Altor BioScience is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer and viral infections, based on its engineered cytokine technology platforms. It was formed in 2002 by Dr. Hing C. Wong as a spin-off from Sunol Molecular Corporation, and is backed by leading venture capital funds, […]
August 29, 2017

CellAegis Devices Product Delivers Automated Remote Ischemic Conditioning (RIC)

CellAegis Devices is a Toronto-based medical device company that has patented and developed the non-invasive autoRIC Device, which delivers Remote Ischemic Conditioning (RIC) therapy to patients with acute and chronic cardiovascular conditions. Remote ischemic conditioning uses sequences of short, controlled periods of reduced or no blood flow (ischemia) in a […]
August 24, 2017

Turner MedTech’s Manufacturing Processes Make Commercialization Easier

Turner MedTech is a company with a primary focus on the manufacture of products for the medical, life science, physical science, and security and defense industries. The company is a division of Turner Innovations, a technology and product development company serving the same industries. Through Turner Innovations and Turner MedTech, […]
August 24, 2017

ResMed’s Products Treat Sleep Apnea, COPD and Other Respiratory Diseases

ResMed (NYSE:RMD) is a company that has been recognized for changing lives with its award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. The company is known as a global leader, servicing over 100 […]
August 24, 2017

Cerebral Assessment System’s Cognivue Looks at Brain Health to Detect Dementia

Cerebral Assessment Systems is a company with a shared philosophy and goal in mind: to make the assessment of cognitive function as routine as having one’s blood pressure checked. Dr. Charles J. Duffy, M.D., Ph.D., is Cerebral Assessment Systems’ founder, and the inventor of the company’s chief product: the Cognivue […]
August 24, 2017

Generex Biotech’s Oral Cavity Drug Delivery System

Generex Biotechnology is a company focused on the research and development of drug delivery systems and technologies. They are currently working on a drug delivery technology via the administration of formulations of large molecule drugs to the oral (buccal) cavity using a handheld aerosol applicator. Generex’s technologies are centered around creating […]
July 31, 2017

ImmunoCellular Therapeutics Targeted Cancer Therapies for Glioblastoma

ImmunoCellular is a L.A.-based clinical stage company developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular’s pipeline includes: a Stem-to-T-cell research program, which engineers hematopoietic stem cells to generate cytotoxic T cells; ICT-121, a patient-specific, dendritic cell-based immunotherapy targeting CD133 found in recurrent glioblastoma; ICT-140, a patient-specific, […]
July 31, 2017

Sierra Oncology’s Cancer Therapies Target the DNA Damage Response Network

Sierra Oncology is a clinical stage drug development company advancing targeted DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer. The company’s lead drug candidate, SRA737, is a highly selective, orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1), a key cell cycle checkpoint and central […]
July 31, 2017

Egaceutical’s Anti-Aging Therapy Reverses the Clock

Aging is defined as the accumulated cellular damage over time that is unrepaired. Cellular damage increases exponentially after puberty. Sirtuin enzymes are normally turned off because evolution designed our cells to be very energy efficient. As humans evolved, the body was unable to allocate energy to sufficiently continue cellular repair […]
July 31, 2017

IR2DX’s Personalized Diagnostics and Analysis Optimizes Care

IR2Dx, Inc. is dedicated to bringing personalized medicine to the field of metabolic control, using precision diagnostics and analysis to enable physicians, health providers and payers to optimize care for their patients. Based in California, the company’s clinical decision support tools, such as the TIGAR Report, have key information to […]
June 7, 2017

ProLung’s Improved Outcomes for Lung Cancer Patients via Early Predictive Technologies

ProLung’s mission is to improve outcomes for potential lung cancer patients through early predictive technologies, provide cost savings to patients, payers, and providers, and to provide a fair return on investment to shareholders and other stakeholders. ProLung is committed to making a positive and significant impact on the healthcare community […]
June 7, 2017

Bioelectronics’ Non-Invasive Electroceutical Medical Devices

BioElectronics Corporation, headquartered in Frederick, Maryland, USA, is the leading company in the field on non-invasive electroceutical medical devices. BioElectronics innovative medical devices safely and effectively treat chronic and acute pain through a unique mechanism of non-invasive sub-sensory neuromodulation. BioElectronics medical devices have been used in a series of high […]
June 7, 2017

TranS1’s Minimally Invasive Spine Technology to Treat Degenerative Conditions of the Spine

TranS1 is a medical device company focused on providing elegant solutions to surgeons that minimize the damage caused by surgical approaches to the spine.   TranS1’s foundational solution, AxiaLIF+, requires only a 2 cm incision size, which reduces blood loss, inpatient stay, and interoperative time – all while achieving a 94% […]